SG11202011861RA - Extract and dermatological composition comprising same, for treating sensitive skin - Google Patents
Extract and dermatological composition comprising same, for treating sensitive skinInfo
- Publication number
- SG11202011861RA SG11202011861RA SG11202011861RA SG11202011861RA SG11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA
- Authority
- SG
- Singapore
- Prior art keywords
- extract
- same
- sensitive skin
- dermatological composition
- treating sensitive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1854794A FR3081705B1 (en) | 2018-06-01 | 2018-06-01 | EXTRACT AND DERMATOLOGICAL COMPOSITION INCLUDING IT FOR THE TREATMENT OF SENSITIVE SKIN |
| PCT/EP2019/064211 WO2019229248A1 (en) | 2018-06-01 | 2019-05-31 | Extract and dermatological composition comprising same, for treating sensitive skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011861RA true SG11202011861RA (en) | 2020-12-30 |
Family
ID=63407394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011861RA SG11202011861RA (en) | 2018-06-01 | 2019-05-31 | Extract and dermatological composition comprising same, for treating sensitive skin |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11857578B2 (en) |
| EP (1) | EP3801580B1 (en) |
| JP (1) | JP7357645B2 (en) |
| KR (1) | KR20210015871A (en) |
| CN (1) | CN112423769A (en) |
| AR (1) | AR117590A1 (en) |
| AU (1) | AU2019276356A1 (en) |
| BR (1) | BR112020023771A2 (en) |
| CA (1) | CA3100594A1 (en) |
| ES (1) | ES2964122T3 (en) |
| FR (1) | FR3081705B1 (en) |
| MX (1) | MX2020012882A (en) |
| SG (1) | SG11202011861RA (en) |
| WO (1) | WO2019229248A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102621138B1 (en) | 2023-05-12 | 2024-01-05 | 주식회사 포레스트에비뉴 | Sheet-free foam mask pack composition and foam mask pack using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2918884B1 (en) * | 2007-07-17 | 2010-01-15 | Oreal | USE OF CULTIVE BACTERIAL EXTRACTS ON THERMAL WATER AS ANTI-REDNESS AGENT |
| FR2920305B1 (en) * | 2007-09-04 | 2010-07-30 | Oreal | USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS. |
| FR2969657B1 (en) * | 2010-12-22 | 2014-02-07 | Fabre Pierre Dermo Cosmetique | NOVEL BACTERIA AND EXTRACTS OF SAID BACTERIUM AND THEIR USE IN DERMATOLOGY |
| FR2969658B1 (en) * | 2010-12-22 | 2014-10-17 | Fabre Pierre Dermo Cosmetique | NOVEL BACTERIA AND EXTRACTS OF SAID BACTERIUM AND THEIR THERAPEUTIC USE |
| CA3042879A1 (en) * | 2016-11-10 | 2018-05-17 | Allergan, Inc. | Methods for alleviating histamine-independent pruritus using neurotoxins |
| FR3065009B1 (en) * | 2017-04-06 | 2020-11-27 | Fabre Pierre Dermo Cosmetique | BACTERIAL SECRETOME FOR USE IN THE TREATMENT OF SKIN LESIONS |
-
2018
- 2018-06-01 FR FR1854794A patent/FR3081705B1/en active Active
-
2019
- 2019-05-31 JP JP2020566988A patent/JP7357645B2/en active Active
- 2019-05-31 CN CN201980035558.4A patent/CN112423769A/en active Pending
- 2019-05-31 WO PCT/EP2019/064211 patent/WO2019229248A1/en unknown
- 2019-05-31 CA CA3100594A patent/CA3100594A1/en active Pending
- 2019-05-31 US US17/059,810 patent/US11857578B2/en active Active
- 2019-05-31 KR KR1020207036864A patent/KR20210015871A/en active Search and Examination
- 2019-05-31 MX MX2020012882A patent/MX2020012882A/en unknown
- 2019-05-31 SG SG11202011861RA patent/SG11202011861RA/en unknown
- 2019-05-31 ES ES19734252T patent/ES2964122T3/en active Active
- 2019-05-31 EP EP19734252.0A patent/EP3801580B1/en active Active
- 2019-05-31 BR BR112020023771-0A patent/BR112020023771A2/en unknown
- 2019-05-31 AR ARP190101482A patent/AR117590A1/en unknown
- 2019-05-31 AU AU2019276356A patent/AU2019276356A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2964122T3 (en) | 2024-04-04 |
| JP2021526373A (en) | 2021-10-07 |
| US11857578B2 (en) | 2024-01-02 |
| AU2019276356A1 (en) | 2020-12-17 |
| AR117590A1 (en) | 2021-08-18 |
| EP3801580C0 (en) | 2023-08-30 |
| CA3100594A1 (en) | 2019-12-05 |
| FR3081705A1 (en) | 2019-12-06 |
| MX2020012882A (en) | 2021-02-18 |
| EP3801580B1 (en) | 2023-08-30 |
| WO2019229248A1 (en) | 2019-12-05 |
| KR20210015871A (en) | 2021-02-10 |
| JP7357645B2 (en) | 2023-10-06 |
| CN112423769A (en) | 2021-02-26 |
| EP3801580A1 (en) | 2021-04-14 |
| US20210353690A1 (en) | 2021-11-18 |
| BR112020023771A2 (en) | 2021-03-23 |
| FR3081705B1 (en) | 2020-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3244819T (en) | Method and device for cosmetically treating dark spots on the skin by means of cryo-cyto-selective cryogenics | |
| EP3657980A4 (en) | Yeast-based masks for improved skin, hair and scalp health | |
| ZA201902275B (en) | Topical dressing composition for the treatment of damaged skin tissue | |
| IL282871A (en) | Systems and methods for skin treatment | |
| EP3476382A4 (en) | Agent for treating powder for cosmetic, powder for cosmetic, and cosmetic formulated using said powder | |
| EP3554310A4 (en) | Packaged skin treatment composition and method | |
| EP3368592A4 (en) | Cosmetic composition, cosmetic, and external preparation for skin | |
| EP3902605A4 (en) | Methods and compositions for treating skin and hair disorders | |
| EP3653196A4 (en) | Cosmetic mask for application to the skin, and method for applying same | |
| EP3849591A4 (en) | Methods and compositions for treating skin diseases | |
| EP3677274A4 (en) | Composition for preventing and treating skin disease comprising substance specifically binding to vimentin-derived peptide | |
| MX2017013819A (en) | Cosmetic method and therapeutic use for fat reduction. | |
| GB2588994B (en) | Combar for skin and hair treatment | |
| EP3461486A4 (en) | Pharmaceutical composition for preventing or treating dementia and improving cognitive function, comprising glasswort extract | |
| EP3466406A4 (en) | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment | |
| SG11202011861RA (en) | Extract and dermatological composition comprising same, for treating sensitive skin | |
| HK1256935A1 (en) | Method and composition for treating cancer or skin lesion using a vaccine | |
| EP3677267A4 (en) | Pharmaceutical composition for tumor treatment or prevention, method, and use thereof | |
| EP3501493A4 (en) | Cosmetic anti-blemish composition, use of the composition, anti-blemish treatment method and application device | |
| GB201611406D0 (en) | Skin care composition and method thereof | |
| IL281501A (en) | Compositions and methods for treating cellulite | |
| PT3515399T (en) | Cosmetic or pharmaceutical composition for skin taughtening, skin fixation and wrinkle reduction | |
| SG11202002451TA (en) | Composition for treating fine dust-caused skin cell damage, comprising prunus mume flower extract | |
| EP3501494A4 (en) | Cosmetic anti-blemish composition, use of the composition and method for anti-blemish treatment | |
| EP3501492A4 (en) | Cosmetic anti-blemish composition, use of the composition, anti-blemish treatment method and application device |